Fernyhough highlighted in TTO newsletter


Posted on: December 7, 2011
Print Friendly Print Get a PDF version of this webpage PDF

Left to right: Mr. Randy Van­Der­Ploeg, Dr. Dar­rell Smith, Dr. Ali Saleh, Dr. Subir Roy Chowd­hury, Dr. Paul Fer­ny­hough, Ms. Maha­lak­shmi Razdan

Dr. Paul Fernyhough, director of the Division of Neurodegenerative Disorders, in collaboration with researchers at the University of Toronto and University of California (San Diego), has demonstrated a compound that can prevent and reverse sensory neuropathy in diabetic rats and mice; the first step towards a commercial product with a current market of $1.41 billion. Yes, that’s billion.

You will want to read more – Dr. Fernyhough ‘s research has recently been highlighted in “Tomorrow’s Technologies Today”, the University of Manitoba’s Technology Transfer Office newsletter.

Click here to go to the newsletter article.